WALTHAM, Mass. — November 5, 2025 — Leads & Copy — Crescent Biopharma, Inc. (Nasdaq: CBIO) will present at healthcare investor conferences in November, including the Guggenheim 2nd Annual Healthcare Innovation Conference, the Stifel 2025 Healthcare Conference, and the Jefferies Global Healthcare Conference. Live webcasts will be available on Crescent’s website, with replays accessible for 90 days.
Crescent Biopharma, a biotechnology company, focuses on rapidly advancing cancer therapies. Its pipeline includes a PD-1 x VEGF bispecific antibody and novel antibody-drug conjugates (ADCs). The company aims to advance transformative therapies for solid tumors, either as single agents or in combination regimens.
Amy Reilly, Chief Communications Officer, can be reached at amy.reilly@crescentbiopharma.com or 617-465-0586.
Source: Crescent Biopharma
